A proposed conflict-of-interest policy would make the doctors, pharmacists and others who serve on Minnesota’s Medicaid Drug Formulary Committee reveal financial relationships with drug companies, including honoraria, past employment and stock ownership. The policy aims to ferret out potential sources of bias.
